Informed Consent

Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.

Participant compensation is often a complicated matter. This blog will shed light on what an IRB considers during its review.

Study-specific screening consent is a subtype of informed consent, which ensures a research participant understands of the research and its risks.

We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.

If your research must comply with the revised Common Rule, you’ll need to update the way you write ICFs to meet the new requirements.

While many US researchers are aware of the coming Common Rule changes, not everyone is sure whether they will need to comply with the revised regulations.

Learn the basics of how ICH-GCP Guidelines can impact the study ICF and how we at Advarra came to our updated policy on the topic.

Let’s take a look at the basics of what each program does and does not do for patients seeking to access investigational therapies.

This blog outlines the principle of equitable selection and the requirement for additional safeguards for certain vulnerable groups.

Recently, the clinical research community has been making efforts to include more diverse subject populations in clinical studies.

eConsent technology can often better inform participants than just the traditional paper consent, which is great from an IRB perspective.

A major element of any IRB review is the examination of potential benefits and risks to study participants.